Anzeige
Mehr »
Login
Freitag, 01.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
200.000 Unzen pro Jahr: Die Goldaktie, die kurz davor steht, Geschichte zu schreiben
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
348 Leser
Artikel bewerten:
(1)

SThree: Final Results -6-

DJ SThree: Final Results

SThree (STEM) 
SThree: Final Results 
25-Jan-2021 / 07:00 GMT/BST 
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 
(MAR), transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
SThree plc 
("SThree" or the "Group") 
 
FINAL RESULTS FOR THE YEAR ENDED 30 NOvember 2020 
 
delivered a resilient performance 
guided by our purpose and our focus on STem 
 
SThree plc, the only global pure-play specialist staffing business focused on roles in Science, Technology, Engineering 
and Mathematics ('STEM'), is today announcing its financial results for the financial year ended 30 November 2020. 
 
FINANCIAL HIGHLIGHTS 
                                                2020                  2019                 Variance 
                                                                                                        Constant 
Continuing operations 
                                               Adjusted (1) Reported Adjusted (1) Reported Movement (2) currency 
excluding discontinued operations in Australia 
                                                                                                        movement (3) 
Revenue (GBP million)                            1,202.6      1,202.6  1,324.7      1,324.7  -9%          -9% 
Net fees (GBP million)                           308.6        308.6    338.0        338.0    -9%          -8% 
Operating profit (GBP million)                   31.3         31.8     60.0         57.7     -48%         -48% 
Operating profit conversion ratio              10.1%        10.3%    17.8%        17.1%    -7.7% pts    -7.6% pts 
Profit before tax (GBP million)                  30.1         30.6     59.1         56.8     -49%         -49% 
Basic earnings per share (pence)               13.9         14.2     33.2         31.8     -58%         -58% 
Proposed final dividend (pence)                5.0          5.0      -            -        n/a          n/a 
Net cash (GBP million) (4)                       49.9         49.9     10.6         10.6     +371%        +371% 

1) Excluding the impact of GBP0.5 million in net exceptional income (2019: GBP2.3 million in net exceptional cost).

(2) Variance compares adjusted 2020 against adjusted 2019 to provide a like-for-like view.

(3) Variance compares adjusted 2020 against adjusted 2019 on a constant currency basis, whereby the prior year foreign exchange rates are applied to current and prior financial year results to remove the impact of exchange rate fluctuations.

(4) Net cash represents cash and cash equivalents less borrowings and bank overdrafts and excludes leases.

FULL-YEAR HIGHLIGHTS - Group net fees for the full year declined 8% YoY*, demonstrating resilience against COVID-19's impact and the

continued recovery of the underlying business in H2. - Full year adjusted profit before tax of GBP30.1 million (2019: GBP59.1 million). - Significant sequential improvement of underlying Group performance in the second half.

- Contractor order book stabilised

- Sales activity and contractor retention rates increased quarter-on-quarter from Q3

- Productivity per head up 4% in H2 YoY - Continued market share gains in the USA, Germany, the Netherlands and the UK despite disruption, in line with 2024

strategic ambitions. - Contract net fees demonstrating resilience, down 7%*. Contract represents 76% of Group net fees (2019: 74%) in line

with strategic focus. - Permanent net fees also showing resilience, down 13%*. - Customer net promoter score improved by eight points to 52, demonstrating the improving quality of our service. - 89% of Group net fees generated outside the UK (2019: 87%). - Very strong balance sheet, with net cash of GBP49.9 million at the year-end (2019: GBP10.6 million). - Resumption of dividend payments with a final dividend proposed of 5.0 pence (2019: nil pence). - Alex Smith, CFO, will be stepping down from his position during 2021 once a suitable successor has been identified.

* In constant currency

Mark Dorman, CEO, commented:

"In 2020 we faced a once in a century event that provided a series of unprecedented tests. SThree not only dealt with those challenges but is emerging as a stronger business; I am proud of the many achievements we are able to list today. Through our unrelenting focus on our strategy, and guided by our purpose, we have taken market share in several of our key regions and delivered robust financial results which underscore our differentiation from non-specialist staffing businesses. Our USA business, for example, has managed to grow net fees 2%* this year against an overall staffing market decline, which is a testament to the quality of our teams there and the strength of our targeted STEM strategy.

Our focus on improving the way we operate, no matter the environment, has delivered increased sales activity, contractor retention rates and the average productivity of our consultants steadily improving since Q3.

Alongside the positive progress in key performance indicators such as these, we have continued to make a real impact on the lives of the people we work with and the society in which we operate. In 2020, we have placed nearly 14,000 of the skilled people who are coming together to build the future, as well as providing comprehensive support to our consultants, clients and communities. Being part of a responsible and sustainable organisation has never been more important and we have shown this is at SThree's core.

Whilst uncertainty remains, we are confident we have the right strategy in place to continue to drive the Group forward towards our long-term ambitions and are highly focused on ensuring we execute on it. Over the coming year we will continue to invest in our people, data, technology, and our go-to market approach, leveraging the power of our platform to reduce the cost of customer and candidate acquisition. Our aim remains to continue taking market share, working towards our ultimate goal of becoming the number one STEM talent provider in the best STEM markets."

A video overview of the results from the CEO, Mark Dorman, and CFO, Alex Smith, is available to watch here: http:// bit.ly/STEM_FY20_overview

Management Succession

The Board also announces that following over twelve successful years with the Group, Alex Smith, CFO, will be stepping down as CFO and a Board Member. The search for his successor is underway and the market will be updated accordingly.

James Bilefield, Chairman, commented:

"On behalf of the Group, I would like to take this opportunity to thank Alex for his excellent contribution over the past twelve years. Alex has worked diligently and effectively with both the Board and our teams to help make SThree what it is today, astutely guiding the Group's entrepreneurial spirit.

It would be remiss not to highlight his work over the past year, through an incredibly difficult environment, to ensure that the Group has retained its financial strength. We are hugely grateful to him for building and maintaining such a strong platform from which we will continue to deliver, and allowing us to focus on executing against our ambitions as we move into our next stage of growth.

Mark Dorman, CEO, added:

"On joining the Group and wider industry, I could not have asked for a better right hand, providing me with sage insight and guidance. It has truly been a pleasure working together and I want to take this opportunity to thank Alex, both from me personally, but also the whole of SThree, and I know we all wish him all the best for the future."

Analyst conference call

SThree is hosting a webinar for analysts today at 09:30 GMT. If you would like to register for the webinar, please contact SThree@almapr.co.uk

SThree will issue its Q1 trading update on 15 March 2021.

Enquiries:

SThree plc 020 7268 6000

Mark Dorman, Chief Executive Officer

Alex Smith, Chief Financial Officer

Steve Hornbuckle, Company Secretary

Alma PR 020 3405 0205

Rebecca Sanders-Hewett SThree@almapr.co.uk

Susie Hudson

Notes to editors

SThree is the only global pure play specialist staffing business focused on roles in STEM (Science, Technology, Engineering and Mathematics). It brings skilled people together to build the future through the provision of specialist Contract and Permanent services to a diverse client base of over 9,000 clients. From its well-established position as a major player in the Technology sector, the Group has broadened the base of its operations to include businesses serving the Banking & Finance, Energy, Engineering and Life Sciences sectors.

Since launching its original business, Computer Futures, in 1986, the Group has adopted a multi-brand strategy, establishing new operations to address growth opportunities. SThree brands include Progressive, Computer Futures, Huxley Associates and Real Staffing Group. The Group has circa 2,600 employees in 15 countries.

SThree plc is quoted on the Official List of the UK Listing Authority under the ticker symbol STEM and also has a USA level one ADR facility, symbol SERTY.

Important notice Certain statements in this announcement are forward looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward-looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Data from the announcement is sourced from unaudited internal management information. Accordingly, undue reliance should not be placed on forward looking statements.

CHair's statement

(MORE TO FOLLOW) Dow Jones Newswires

January 25, 2021 02:02 ET (07:02 GMT)

DJ SThree: Final Results -2-

Never has a year been more different than what we had expected. In November 2019 we set out our purpose, strategy and ambitions at our Capital Markets Day with excitement and confidence for the years ahead. Whilst our first year following this path has seen us, and the wider world, face a myriad of unexpected challenges, we have remained resolute in our focus and determination to deliver on those ambitions. I am pleased to say that we have made significant progress along that path. We have delivered financial performance above previous market expectations and are outperforming our peers on many measures, demonstrating the resilience of our model with its recurring revenue and attractive cash characteristics, alongside our strength of focus and clarity of strategy.

We have seen our purpose - bringing skilled people together to build the future - brought to life this year more than ever. Our teams worked closely with our clients and candidates to be their partner through the COVID-19 health crisis and gradual emergence of a 'new normal', filling key STEM roles at a time of extraordinary upheaval.

Internally, our leadership team brought our people together and showed decisiveness, strength and sensitivity. This year has been tough on all of us, and I would like to take this opportunity to thank the exceptional teams around the world at SThree not only for their hard work, but also for their fortitude and endurance in such challenging times.

The Board has worked hard during the year to act in the long-term interests of all stakeholders, balancing complex and sometimes conflicting interests and priorities. We implemented a number of cost management initiatives which were required during the year, but also were able to maintain necessary investment in the future of the Group, notably in technology and some key appointments to drive operational change, project delivery and agility.

Whilst the health crisis and its economic impacts will eventually pass, we believe that the recent acceleration in the two key long-term, secular trends at the heart of our strategy - STEM and flexible working - will continue to grow in importance around the world as we all look to build a better future. That will require ongoing investment in operational scale, agility and effectiveness, together with ever-closer client and candidate relationships.

The effective use of data will be critical to success in that environment. We have already established a comprehensive market intelligence programme to ensure that we understand what is most important to our clients and candidates, both now and in the future, and we plan to grow our expertise, staying ahead of the curve in the coming years.

Lastly, but importantly, during the year we have deepened our focus on the Group's impact on the wider world and the communities in which we operate. Whilst Environmental, Social and Corporate Governance ('ESG') has long been on the agenda at SThree, it is now increasingly woven into everything we do, with particular emphasis on building a green future, developing a fully inclusive workforce and ensuring that we operate our business to the highest ethical standards, overseen by FTSE 250-appropriate corporate governance.

Our opportunity is significant, our strategy is right and the improving sequential trends in our specialist STEM markets are favourable. We remain confident that the Group is primed to deliver for the long-term benefit of all of our stakeholders.

CHIEF EXECUTIVE OFFICER'S STATEMENT

Our purpose of 'bringing skilled people together to build the future' has never been more relevant and we have the right strategy, positioned at the centre of the secular trends of STEM and flexible working, to best capitalise on this growing opportunity in the future.

As an example, our DACH business explored new opportunities within Life Sciences in the period, working closely with BioNTech - our client in Germany - to place the experts leading the research efforts to find a vaccine for COVID-19. In the UK, we worked closely with Thermo Fisher Scientific - a global life sciences company specialising in pharma, IVD, and medical devices - in placing medical device professionals across validation, quality, and regulatory roles. In the USA, our specialist IT team has worked alongside a higher education institution - Teachers College of Columbia University - to implement the digital infrastructure that enables them to build virtual communities for the incoming college students. Further examples of our purposeful work in the year can be found in our 2020 Annual Report and Accounts.

At our Capital Markets Day in November 2019, we set out a clear strategy and in the first quarter were delivering in line with it. As the global health crisis accelerated, rapid adjustments to our business were made to ensure that we were able to best look after our teams, service our clients and navigate the new economic and working landscape. I am pleased to say that we never lost sight of our purpose or our strategy, and these principles continue to guide us.

This unrelenting focus on our strategy has delivered a financial performance ahead of where we reset our expectations when COVID-19 first hit. Group net fees in the year were down only 8%*, with Contract net fees showing particular resilience with a 7%* decline. We have continued to take market share in the USA, Germany, the Netherlands and the UK and made progress against several of our 2024 ambitions. In the second half of the year, as our strategic management of the crisis took effect, we saw significant sequential improvement of Group performance with sales activity, contractor retention rates and consultant productivity increasing quarter-on-quarter from Q3.

Despite all the challenges this year, it is evident from our performance that we have the right strategy, are in the right markets and our teams are executing well. While 2020 has not turned out as we had thought it would at our Capital Markets Day in November 2019, what is clear is that we are well positioned for the future and for capturing the growth opportunities ahead. The key strategic ambitions we outlined at the Capital Markets Day, if anything, have been reinforced by our experience and actions over the last year.

Our response to the health crisis

As we saw the impact of the virus starting to take shape across the globe, on 28 February we set up a dedicated COVID-19 health crisis team made up of key senior managers from across the business, tasked with monitoring operations and reacting as appropriate. The committee met daily to make sure all possible action to help mitigate any impact were considered and then taken quickly and effectively, ensuring that the Group kept its people safe, could operate regardless of the conditions and maintain its financial strength. So that we would be in a strong position to continue executing on our growth strategy, we created a framework for the organisation to work with. This involved breaking the crisis down into operational phases, each with its own set of priorities; these phases were Emergency Response, Ongoing Crisis Management and Recovery to the Next Normal.

As the virus moved from mainland China and become a global health crisis, we saw an immediate impact across all our markets. Our Emergency Response was triggered, focused on maintaining the safety of our people, candidates and clients whilst at the same time maintaining the full operational capability of the Group. We were able to quickly and efficiently adjust, as around 98% of our employees began working from home. Despite these changes, our teams went above and beyond to serve our customers and meet their objectives.

The wellbeing and engagement of our team has been an ongoing priority. With over 95% of our colleagues continuing to work remotely, we've made sure we are providing them with all the necessary tools to operate effectively. We have supplied support digitally ranging from advice on how to manage remote teams and guidance on remote working, through to full online learning and development programmes. Having the tools to operate effectively doesn't just mean physically, and in order to protect the wellbeing of our employees we launched our THRIVE wellbeing platform in May offering comprehensive support and advice on the areas of identified concern. Under this banner, we've also hosted a number of roundtable discussions on working from home where our people shared their tips on how to get by in lockdown. 'Build trust' and 'Care then act' are two of our three operating principals, and as an organisation, we've whole-heartedly embraced these as working hours have become more flexible to adapt to personal commitments.

We have also created dedicated resources on our digital platforms for our candidates, to ensure that they are fully supported, with information, articles and guidelines on remote working, as well as information on how to contact us and other tips for getting through the health crisis. Illustrating the success of these programmes, our net promoter score ('NPS') from our clients and candidates has improved by eight points to 52.

I am proud to say that our teams have helped to place many candidates whose STEM talent is being utilised to solve the health crisis. As an example, in DACH we were able to place multiple freelancers in key roles with leading pharmaceutical and biotechnological companies, supporting the development of potential COVID-19 vaccine candidates. In the USA we collaborated on a large-scale Clinical Research Associate ('CRA') project, quickly deploying over 50 CRAs nationally to help in the fight to treat COVID-19.

(MORE TO FOLLOW) Dow Jones Newswires

January 25, 2021 02:02 ET (07:02 GMT)

DJ SThree: Final Results -3-

We implemented a number of initiatives to ensure the business remained on a strong financial, as well as operational, footing throughout this period. These proved very successful, and I am pleased that following an increase in sales activity levels in Q3 (particularly in Contract) coupled with the strength of the balance sheet, we were able to repay all furlough support that we had previously claimed from the UK Government. We also repaid the RCF of GBP50.0 million which was drawn down at the beginning of the lockdown period but not utilised. We also resumed a modest share buy-back programme to satisfy employee ownership plans, further demonstrating our confidence in the business.

The impact of the health crisis on society has been wide-ranging and has magnified the inequalities that already existed. It has disproportionately impacted younger people, people of colour and women and this, together with other events in the year, have shone a spotlight on diversity. In response we focused on strengthening and broadening our existing work on the issue, launching a global D&I strategy in April 2020. We created local focus groups, with regional leads and advocates to support progress in our business, and are working with community partners, clients and candidates to build programmes to open up pathways into STEM careers for people from diverse backgrounds. Our ambition is to be recognised as a global D&I leader in the staffing industry.

Leveraging our position at the centre of STEM

We have always had close relationships with our clients and candidates, but the health crisis has in many ways brought us even closer. We are working with our clients to not only source the best talent to help them deal with changing business conditions now, but also providing guidance on what skills they will likely need in both the immediate future and the longer term. The health crisis has undoubtably broadened minds to flexible working and its ability to decrease the barriers of physical geography, providing access to broader talent pools. This is where being the only global pure-play specialist staffing business focused on STEM really comes into its own as we have access to niche talent across the world that we are now able to offer more widely to global clients.

Alongside this, we believe our position in STEM markets should be a force for good, for clients, candidates, and our STEM experts of the future. We have therefore launched a number of initiatives to nurture interest in our chosen industries. One of these is our STEM Series, where we have collaborated with industry experts to run Thought Leadership events addressing topics such as career barriers, diversity in STEM and personal development. We are pleased that over 2,750 people joined us over the series to pursue their professional development. At the same time, we are working with community partners and clients to deliver virtual events specifically for young people from underserved communities, helping them understand pathways into STEM careers.

As well as cultivating future STEM talent, we began work supporting people at risk of unemployment and underemployment in the USA with the launch of our STEM Career Pathways programme there in August. Within the programme candidates volunteer their time to mentor students, developing their own leadership and coaching skills whilst supporting the next generation of diverse tech talent. We will expand this programme into other markets in 2021.

A business set for now and the future

We still face, what is at its core, a health crisis, and while governments and scientists across the globe continue to develop strategies to contain the virus and so long as the resulting economic and other impacts persist, we expect to see significant continued volatility in our markets. However, in line with our approach at the outset of the health crisis we are committed to learn and adapt so we can operate in whatever environment we are presented with. We have shown that we are capable of overcoming the challenges by adapting to the next normal. Our teams have shown remarkable resilience during these challenging times and we have shown that we can deliver in whatever environment we are presented with.

As a result of our strategic focus on STEM and flexible working, the current environment and its acceleration of those trends, our proposition is proving to be highly relevant. Whilst the crisis has had a significant impact on the overall recruitment market, demand for STEM roles has been robust. These roles have been crucial in supporting both the global response to the crisis and the widespread adoption of digital transformation accelerated by different restrictions. Alongside this, our second secular trend of flexible working has continued to become more prevalent. There has been a seismic shift in working practices prompted by the health crisis and we believe many businesses will now be adopting these for the long term.

Whilst a number of the initiatives we introduced in the period were immediate reactions to the health crisis, we remain focused on building for the future, led by our purpose and strategy. It remains difficult to know what lies ahead and what the future will look like, but it is clear that we are going to see lasting consequences of the current health crisis and the way it has changed the way we work. Given our position at the centre of the two secular trends we are confident that we are well placed to capitalise on this new world of work, and so we are investing in the areas that we are confident will build the infrastructure to support our ambitions and drive our growth. We are committed to the use of data and insights to drive the business, investing in the right tools and technology, continued learning and development and focusing on the right markets, and will continue to do so to position us for the future.

Responsible business

Our purpose of bringing skilled people together to build the future feels even more appropriate today. We source, nurture and place STEM talent with clients who are solving complex world challenges, we connect clients with talent who will contribute solutions to society. Our goal is to truly embed ESG within our business and we have been building out our ESG strategy; identifying three key areas we can have the most impact and introducing new targets to increase our accountability. We are committed to building a sustainable future and the unprecedented events of this year have strengthened our resolve. A more detailed review of the Group's ESG Strategy is available in the Group's Annual Report and Accounts 2020.

Outlook

Our initial view, taken in spring 2020, that this health crisis will create sustained and significant volatility in staffing demand has proven to be correct, and we continue to see uncertainty ahead in several of our markets as restrictions wax and wane across the globe.

Our strategy so far has proven successful and we will continue to drive the Group forward in the coming period towards our long-term ambitions. As we continue to head into the fourth industrial revolution accelerated by the current health crisis, the secular trends of STEM and flexible working will only become more powerful over the next year. We see the world's 'winning' organisations embracing STEM skills in order to thrive, just as those businesses less well suited to the current environment appreciate that they must adapt for the new world quickly to be able to survive. We are therefore highly focused on first-class strategic execution across the business, ensuring we are best able to capitalise on the opportunity available to us.

Over the coming year we will continue to invest in our people, data, technology, and our go-to market approach, leveraging the power of our platform to reduce the cost of customer and candidate acquisition. Our ultimate aim remains to continue taking market share, working towards our ultimate goal of becoming the number one STEM talent provider in the best STEM markets.

Group OPERATIONAL REVIEW

Overview[1]

As a Group, we have delivered a resilient performance for the period, despite the impact of the COVID-19 health crisis. As previously noted, this drove an aggregate drop in demand across all our territories and sectors in Q2, although we have seen a steady recovery in our performance throughout the second half.

Performance has been varied across different regions, sectors and within specific niches. From a regional perspective the USA and Germany continue to perform particularly well, delivering very strong results given the circumstances. Our strategic focus on Contract has also provided the business with greater resilience in the more uncertain economic conditions we have faced. Pleasingly, Permanent has also held up well with DACH, our largest Permanent market, delivering net fees down only 3%*.

Whilst broader market conditions for staffing continue to be challenging, the STEM markets have been robust in comparison and we are confident we can maximise our opportunities with strategic initiatives and selective headcount growth. In what has been a more difficult period for our teams, the quality of our management and increasing expertise in our niche markets is driving us forward on our journey to become the number one STEM talent provider in the best STEM markets. We are committed to ensuring that SThree is well positioned over the long term and are confident we can continue to exploit the accelerating secular trends of STEM and flexible working across global markets and deliver our long-term ambitions.

2024 ambitions

In 2019, looking ahead to 2024 we set ourselves several ambitions to deliver growth and value for our Company and all stakeholders: - to grow Group market share by 50%; - to reach an operating profit conversion ratio in the range of 21-24%; and - to drive a free cash flow conversion ratio of at least 75%.

(MORE TO FOLLOW) Dow Jones Newswires

January 25, 2021 02:02 ET (07:02 GMT)

DJ SThree: Final Results -4-

Alongside this we committed to several targets regarding our people and society that reflect the importance we put on being a people-centric and purpose-driven business. For example, to maintain our Learning & Development ('L&D') spend at 5% of operating profit, to grow productivity per head over the period by 1% to 2% per annum and to reduce our absolute CO2 emissions by 20%.

We have made good progress taking market share in the USA, Germany, the Netherlands and the UK in the period. Whilst the operating profit conversion ratio naturally declined to 10.1% as a result of the impact of the health crisis, our free cash flow conversion rapidly accelerated up 168%, thanks to a focus on cash management alongside the nature of our Contract-focused business model. Within our People and Society goals we are delighted to have maintained our L&D spend at 5% in this crucial period for supporting consultants, and also to have reduced our CO2 emissions by 56%. Whilst overall productivity per head declined 3% YoY as a direct impact of health crisis-related disruption, we are very pleased to have achieved a strong sequential improvement over the second half, which was up 4% YoY, demonstrating the strength of our strategy and our ability to embrace our challenging environment and focus on operating effectively regardless of the physical restrictions.

Group

Net fees by division 
Movement YoY (in constant currency)           2020 mix 
Contract         Permanent    Total  Contract        Permanent 
-7%              -13%         -8%    76%             24% 
 
Breakdown of net fees  2020 2019 
Geographical split 
EMEA excluding DACH    38%  42% 
DACH                   34%  32% 
USA                    25%  23% 
APAC                   3%   3% 
                       100% 
                            100% 
 
Sector split 
Technology             45%  45% 
Life Sciences          23%  20% 
Engineering            22%  21% 
Banking & Finance      8%   11% 
Other sectors          2%   3% 
                       100% 100% 

Operational review by reporting segment

EMEA excluding DACH (38% of Group net fees)

Net fees by division 
Movement YoY (in constant currency)           2020 mix 
Contract         Permanent    Total  Contract        Permanent 
-15%             -26%         -16%   86%             14% 
 

EMEA excluding DACH comprises businesses in Belgium, the Netherlands, Luxembourg, France, Spain, the UK, Ireland and Dubai.

Highlights - Development of localised customer-centric strategies in the UK has seen an increase in customer penetration. - High value employed contractor model in the Netherlands remains resilient throughout the health crisis. - Building very strong client and candidate relationships in the Netherlands has allowed us to outperform and take

market share.

Net fees performance

Net fees have declined in EMEA excluding DACH, down 16%* YoY, primarily driven by the more challenging performance in the UK.

The Netherlands, our largest country in the region, has shown resilience - down 10%* in total - with strong performances in Engineering (up 20%*) and Life Sciences (up 6%*) reflecting the strategic focus of our teams.

Our business in Dubai was down 11%*; however, Banking & Finance has grown 13%*.

Strategic progress

During the year we have focused on our customer relationships to deliver value and as a result have taken further market share in the Netherlands and the UK. Data has been the key driver behind our investment decisions, enabling us to identify changing customer demands and requirements, so that we can then utilise our position of strength within STEM and flexible working to cater to those demands.

We have supported our people throughout the year and introduced flexible working during the health crisis as their safety and well-being is our top priority. Diversity and inclusion programmes have been driven from the top and will continue into the new financial year.

DACH (34% of Group net fees)

Net fees by division 
Movement YoY (in constant currency)           2020 mix 
Contract         Permanent    Total  Contract        Permanent 
-3%              -3%          -3%    65%             35% 
 

DACH is our second largest region comprising businesses in Germany, Switzerland and Austria; Germany accounts for 92% of net fees.

Highlights - Winner of Mittelstand Deutschland Top Employer 2020 for the fourth consecutive year. - Successful re-organisation of our management infrastructure towards our 2024 strategic goals. - Resilient performance despite significant challenges in trading conditions due to our leadership in highly

specialised STEM markets, resulting in growth in market share.

Net fees performance

Our DACH region had a resilient performance in the year driven by significant growth achieved in Q1.

Whilst Q2 was impacted by COVID-19, the region showed good resilience in the second half of the year with a very strong performance considering the challenging macro-environment.

Net fees were down 3%* overall YoY.

Life Sciences has been the standout sector with growth of 4%* driven by an exceptionally strong Q1 and increased demand in Quality Assurance and Clinical Research and Development in the second half of the year. Switzerland, although a small part of the region, has shown strong growth of 31%*.

Strategic progress

We have continued to invest in our Market Intelligence tool and have seen a growth in our STEM market share, which helps us to become a leader in our top STEM specialist markets.

Our people are key to us - therefore, we are continuously developing our employer value proposition and have made it our top priority to protect our people and create a safe working environment for them in the light of the global health crisis. This has resulted in being awarded the Top Employer Award (Mittelstand) for the fourth consecutive year.

USA (25% of Group net fees)

Net fees by division 
Movement YoY (in constant currency)           2020 mix 
Contract         Permanent    Total  Contract        Permanent 
+4%              -7%          +2%    80%             20% 
 

The USA is the world's largest specialist STEM staffing market. The region remains a key area of focus for the Group and we will continue to strategically invest in it as we align our resources with the best long-term opportunities.

Highlights - 2%* net fee growth against a declining STEM market. - 16%* Life Sciences growth driven by focus on high value skill verticals and customer projects. - Exceptionally resilient performance of the Permanent division with Q4 growth of 6%*.

Net fees performance

The USA business has demonstrated its strength with net fees up 2%* for the year and up 11%* in Q4. This is a considerable achievement given the challenging macro-environment and this region has shown the benefits of investing in the right vertical niches and deeply understanding customer needs.

Performance in our Life Sciences business has been particularly strong, with net fees growing 16%* in the year. We have seen robust demand in the second half of the year in Clinical Operations, Product Development and Quality Assurance. Our Technology business has grown 9%*, with increased demand in Mobile Applications & Software Development, and Engineering was up 1%*.

Strategic progress

The USA business has continued to focus on high value skill niches resulting in an improvement in Contract gross margin since Q1 2018. During 2020 we have partnered with our clients to deliver critical projects ranging from digital transformation (mobile application development) to the development and deployment of COVID-19 vaccines, therapies and testing. We have increased our market share, whilst we stay true to our purpose and executing robustly on our strategy.

Asia Pacific (3% of Group net fees)

Net fees by division 
Movement YoY (in constant currency)           2020 mix 
Contract         Permanent    Total  Contract        Permanent 
-8%              -30%         -26%   20%             80% 
 

Our APAC business principally includes Japan and Singapore. APAC represented 3% of Group net fees, in line with prior year.

Highlights - Focus on clients with digital transformation demands. - Built leadership capability in Japan and Singapore. - Exited Australia in the final quarter.

Net fees performance

Net fees for our Asia Pacific ('APAC') region were down 26%* in the full year, primarily driven by the more transactional nature of our business in Japan, which is 94% Permanent. Our Japanese business was down 25%* in the year with all sectors impacted.

Singapore net fees were down 29%* in the year, with business impacted across all our sectors.

Strategic progress

We have taken the opportunity this year to focus on our brand identity and value proposition, and - as a result - delivered targeted solutions for the success of our clients. In line with our strategy and purpose, we are strengthening our position in STEM, with a clear focus on Technology and Life Sciences. People remain at the heart of our business and we have reviewed our career programmes, provided robust digital learning and continue to support our people during this challenging period.

chief financial officer's REVIEW

When the health crisis struck, we responded thoughtfully and at pace. We protected liquidity and accelerated our scenario planning, all whilst working remotely. As the year progressed, the Group executed well and delivered a resilient performance, ahead of our expectations when COVID-19 first hit. Our strong balance sheet and immediately-accessible liquidity of GBP154.9 million give us confidence and position us well for the future.

Income statement

Revenue for the year was down 9% on a reported and constant currency basis to GBP1.2 billion (2019: GBP1.3 billion). Net fees decreased by 9% on a reported and 8% on a constant currency basis to GBP308.6 million (2019: GBP338.0 million).

(MORE TO FOLLOW) Dow Jones Newswires

January 25, 2021 02:02 ET (07:02 GMT)

DJ SThree: Final Results -5-

Despite the negative implications of the COVID-19 health crisis, the Group succeeded in improving underlying sequential performance in the second half and delivered a resilient result for the full year. The demand for contract staff accelerated and our contractor book stabilised due to new deal activity and improved contractor retention rates in the second half. At the end of the year, Contract represented 76% of the Group net fees in the period (2019: 74%). Our net fees margin increased to 25.7% (2019: 25.5%).

Operating expenses decreased by 1.2% on a reported basis, mainly attributable to a reduction in personnel and miscellaneous costs. The slowdown in the Group's operations caused by the COVID-19 health crisis led to a pause in marketing spend, a decline in commissions and bonuses, and a temporary reduction in the Senior Executives' salaries. The Group also benefited from the government job retention support schemes in selected countries.

The Group's financial results were impacted by certain significant items of expense and income. - The impairment charge of GBP1.1 million was recognised for underperforming internally developed assets which were

assessed as no longer recoverable in the course of normal operations. - In response to the significantly changed economic environment and increased risk and uncertainty caused by

COVID-19, we took steps to right size the structure and strategy of certain local businesses. These changes will

optimise SThree's resilience in the future. A charge of GBP3.3 million was recognised in the current year. - During the year, the Group took advantage of job retention schemes launched by a number of national governments,

whereby a portion of salaries was reimbursed for furloughed staff. In 2020, the total benefit, including the

associated payroll savings, was GBP1.2 million (2019: GBPnil). The compensation was presented as a deduction in

reporting the related staff expense. The Group decided to repay UK furlough money as performance exceeded the

Directors' expectations and is therefore not included in the above figure.

The reported operating profit was GBP31.8 million, down 45% YoY (2019: GBP57.7 million). The adjusted operating profit of GBP31.3 million (2019: GBP60.0 million) excluded exceptional income of GBP0.5 million in respect of the government grant receivable from Scottish Enterprise on the relocation of support functions (2019: GBP2.3 million primarily in respect of the CEO changes and restructuring of senior leadership).

Our operating profit conversion ratio decreased by 6.8 percentage points to 10.3% on a reported basis and 7.7 percentage points to 10.1% on an adjusted basis (2019: reported 17.1% and adjusted 17.8%).[2] The YoY movement reflects the overall slowdown in the Group trading activity in the light of the health crisis, partially offset by cost management initiatives implemented during the year in response to the crisis.

In line with our revised strategy and ambition to be the number one talent provider in the best STEM markets in which SThree has the highest opportunity to take market share, we ceased our operations in Australia. Its results were taken out of the above analysis for both the current and prior years. In 2020, the discontinued operations incurred an operating loss of GBP1.8 million (2019: breakeven), including exit costs of GBP1.1 million.

Net finance costs

Net finance costs increased to GBP1.2 million (2019: GBP1.0 million), which was a result of the full drawdown of the RCF to ensure strong liquidity in the first half plus the adoption of the new standard IFRS 16 on leases.

Foreign exchange exposure

For 2020, the YoY movements in exchange rates between Sterling, the Euro and the US Dollar (the main functional currencies of the Group) provided a moderate net headwind to the reported performance of the Group, reducing our reported net fees by approximately GBP1.0 million and operating profit by GBP0.2 million.

Exchange rate movements remain a material sensitivity. By way of illustration, each one per cent movement in annual exchange rates of the Euro and US Dollar against Sterling impacted our 2020 net fees by GBP1.8 million and GBP0.8 million respectively, and operating profit by GBP0.5 million and GBP0.3 million respectively. Our foreign exchange risk management strategy involves using certain derivative financial instruments to minimise the transactional exposure arising from currency fluctuations.

Income tax

The tax charge on the Group's adjusted profit before tax was GBP11.7 million (2019: GBP15.9 million) for the year, representing an effective tax rate ('ETR') of 41.5% (2019: 26.9%). The ETR on the Group's reported profit before tax was 41.1% (2019: 27.3%).

The ETR on continuing operations was 39.0% before exceptional items and 38.7% after exceptional items.

The Group's ETR primarily varies depending on the mix of taxable profits by territory, non-deductibility of the accounting charge for LTIPs and other one-off tax items.

In 2020, the extent to which tax credits on loss-making businesses were recognised had a material impact on the Group ETR. The COVID-19 health crisis increased the ratio of operating losses as a proportion of the absolute profits and losses of the Group. This, together with the reduction in Group results, resulted in the non-recognition of tax credits on loss-making businesses. The Group is affected by the European Commission's investigation into the state aid received by foreign subsidiaries controlled by SThree plc. Whilst this was noted as a contingent liability in 2019, in 2020 it was determined that it was no longer probable that the uncertain tax treatment surrounding this issue will be accepted. As such, a provision for GBP1.3 million was recognised and this also impacted the Group ETR.

Overall, the reported profit before tax from continuing operations was GBP30.6 million, down 46% YoY. The adjusted profit before tax from continuing operations was GBP30.1 million, down 49% YoY (2019: reported GBP56.8 million and adjusted GBP59.1 million).

Our reported profit after tax from continuing operations was GBP18.8 million, down 55% YoY. The adjusted profit after tax from continuing operations was GBP18.4 million, down 57% YoY (2019: reported GBP41.3 million and adjusted GBP43.2 million).

Earnings per share ('EPS')

On an adjusted basis, EPS was down 58%, at 13.9 pence (2019: adjusted 33.2 pence), due to a decrease in the adjusted PBT, an increase in the Group's ETR, and a 2.2 million increase in weighted average number of shares. On a reported basis, EPS was 14.2 pence (2019: 31.8 pence), down 17.6 pence on the prior year, attributable mainly to a decline in trading performance as explained above. The weighted average number of shares used for basic EPS grew to 132.1 million (2019: 129.9 million). Reported diluted EPS was 13.8 pence (2019: 30.9 pence), down 17.1 pence. Share dilution mainly results from various share options in place and expected future settlement of certain tracker shares. The dilutive effect on EPS from tracker shares will vary in future periods depending on the profitability of the underlying tracker businesses and the settlement of vested arrangements.

Dividends

Due to the prevailing uncertainty caused by the COVID-19 health crisis, the Board did not propose to pay the 2020 interim dividend (2019: 5.1 pence).

With underlying sequential improvements noted across the Group in the second half, and in the light of the Group's continued, robust financial position, the final dividend has been proposed at 5.0 pence and will be subject to shareholder approval at the 2021 Annual General Meeting. Despite the improved financial performance of the Group, the Board remains cognisant of the heightened volatility facing the Group and will continue to keep the capital allocation policy under review.

Balance sheet

Total net assets increased to GBP128.5 million (2019: GBP116.8 million), driven by the excess of net profit over the reduced dividend payment, favourable foreign currency, offset by the adoption of IFRS 16 and share buy-backs. Our trade receivables (including Contract assets) declined to GBP226.8 million (2019: GBP256.2 million) reflecting lower revenue and due to enhancements in credit risk management to preserve cash and provide greater clarity on the financial viability of the trade debtor book. Days sales outstanding remained level at 44 days (2019: 44 days).

Investment in subsidiaries (Company only)

Following the review of the recoverable amount of the Company's own portfolio of investments, a total impairment loss of GBP13.2 million was recognised. It was mainly in respect of the UK operation, which experienced increased risk, uncertainty, and reduced economic activity caused by COVID-19.

After booking this impairment, the retained earnings were GBP87.2 million (2019: GBP122.0 million).

Tracker shares

Only an immaterial number of tracker shares were settled during the year as the annual buy-out process was postponed (2019: tracker shares were settled for a total consideration of GBP4.4 million). In 2020 we settled the consideration in SThree plc shares by utilising 33,949 treasury shares. In the prior year, we settled the consideration for vested tracker shares in SThree plc shares either by issuing new shares (2019: 475,738) or treasury shares (2019: 974,583). Consequently, the arrangement is deemed to be an equity-settled share-based payment arrangement under IFRS 2 Share-based payments. There is no charge to the income statement as initially the tracker shareholders subscribed to the tracker shares at their fair value. We expect future tracker share settlements to be circa GBP5.0 million per annum. These settlements may either dilute the earnings of SThree plc's existing ordinary shareholders if funded by new issue of shares or will result in a cash outflow if funded via Employee Benefit Trust shares.[3]

Liquidity management

(MORE TO FOLLOW) Dow Jones Newswires

January 25, 2021 02:02 ET (07:02 GMT)

DJ SThree: Final Results -6-

In 2020, cash generated from operations on an adjusted basis increased to GBP76.9 million (2019: GBP54.8 million). It represented the net result of reduced adjusted EBITDA offset by the release of working capital as the business slowed down, strong action to manage working capital in the face of the COVID-19 health crisis, reduced taxes paid and reclassification of rent payments to financing activities under the newly implemented standard, IFRS 16 Leases.

Capital expenditure increased to GBP5.3 million (2019: GBP4.6 million). The Group made only essential capital investments to support the ongoing pursuit of strategic priorities under the fast-evolving market conditions.

Income tax paid decreased to GBP10.5 million (2019: GBP12.9 million), and dividend payments reduced to GBP6.7 million (2019: GBP18.8 million) as a result of the withdrawal of the proposed final 2019 dividend. The Group paid GBP13.6 million in rent (2019: GBP14.6 million) and GBP0.4 million (2019: GBP0.9 million) in net interest cost in the year. The Group paid GBP2.0 million (2019: GBP2.5 million) for the purchase of its own shares to satisfy employee share schemes in future periods. Cash inflows of GBP0.9 million (2019: GBP0.3 million) were generated from Save As You Earn employee schemes. Foreign exchange had an immaterial impact.

Overall, in 2020, the Group free cash conversion ratio increased to 178% on an adjusted basis compared to the prior year of 68%, primarily reflecting improved working capital. We started the period with net cash of GBP10.6 million and closed the period with net cash of GBP49.9 million.

Borrowings

On 30 November 2020, the Group had total accessible liquidity of GBP154.9 million. This was made up of GBP49.9 million net cash, a GBP50.0 million Revolving Credit Facility ('RCF'), which is committed to 2023, a GBP5.0 million overdraft and GBP50.0 million under the Bank of England's COVID Corporate Financing Facility available until March 2021, with none of these debt facilities drawn down at year end. In addition, SThree has a GBP20.0 million accordion facility as well as a substantial working capital position reflecting net cash due to SThree for placements already undertaken.

At the year end, the funds borrowed under the RCF bear interest at a minimum annual rate of 1.3% above a three-month Sterling LIBOR, giving an average interest rate of 1.3% during the period (2019: 2.0%).

These demonstrate that the Group remains in a strong financial position and has sufficient cash reserves to meet its obligations as they fall due for a period of at least 12 months from the date of signing of these financial statements. The Board therefore considers it appropriate to adopt the going concern basis of accounting in preparing these Consolidated Financial Statements.

PRINCIPAL RISKS

Principal risks and uncertainties affecting the business activities of the Group are detailed within the Strategic Report section of the Group's 2020 Annual Report, a copy of which will be available on the Group's website www.sthree.com.

Delivering on our strategy requires all parts of our business to work together. In isolation risk mitigation helps SThree manage specific subjects and areas of the business. However, when brought into our day-to-day activities successful risk management has helped us to maximise our competitive advantage and deliver on our strategic pillars in 2020. Whilst the ultimate responsibility for risk management rests with the Board, the effective day-to-day management of risk is in the way we do business and our culture.

Aligning risks and strategy by using risk to help make the right strategic decisions - in order to deliver our strategy and competitive advantage throughout the business we must ensure that we maintain a balance between safeguarding against potential risks and taking advantage of all potential opportunities.

consolidated income statement

for the year ended 30 November 2020

2020            2019 
                                   Before exceptional Exceptional           Before          Exceptional 
                                   items              items       Total     exceptional     items       Total 
                                                                            items 
  Note                             GBP'000              GBP'000       GBP'000     GBP'000           GBP'000       GBP'000 
Continuing operations 
 
Revenue                        2     1,202,622        -           1,202,622 1,324,703       -           1,324,703 
Cost of sales                  (894,047)              -           (894,047) (986,707)       -           (986,707) 
 
Net fees                       2     308,575          -           308,575   337,996         -           337,996 
Administrative (expense)/      3     (275,594)        468         (275,126) (275,592)       (2,273)     (277,865) 
income 
Impairment losses on financial 3     (1,689)          -           (1,689)   (2,376)         -           (2,376) 
assets 
 
Operating profit                         31,292       468         31,760    60,028          (2,273)     57,755 
 
Finance costs                            (1,279)      -           (1,279)   (1,009)         -           (1,009) 
Finance income                                114     -           114       55              -           55 
 
Profit before income tax             30,127           468         30,595    59,074          (2,273)     56,801 
Income tax (expense)/benefit   4     (11,744)         (89)        (11,833)  (15,908)        428         (15,480) 
 
Profit for the year from             18,383           379         18,762    43,166          (1,845)     41,321 
continuing operations 
Discontinued operations        5 
Loss after tax for the year          (1,809)          -           (1,809)   (2)             -           (2) 
from discontinued operations 
 
Profit for the period attributable 16,574             379         16,953    43,164          (1,845)     41,319 
to owners of the Company 
 
Earnings per share             7     pence            pence       pence     pence           pence       pence 
Basic                                      12.5       0.3         12.8      33.2            (1.4)       31.8 
Diluted                                       12.2    0.3         12.5      32.3            (1.4)       30.9 
 
Earnings per share for         7         pence        pence       pence     pence           pence       pence 
continuing operations 
Basic                                         13.9    0.3         14.2      33.2            (1.4)       31.8 
Diluted                                       13.5    0.3         13.8      32.3            (1.4)       30.9 
 
 

The above Consolidated Income statement should be read in conjunction with the accompanying notes.

consolidated statement of comprehensive income 
for the year ended 30 November 2020 
 
 
                                                                                           2020    2019 
                                                                                            GBP'000   GBP'000 
 
Profit for the year                                                                        16,953  41,319 
 
Other comprehensive income/(expense): 
Items that may be subsequently reclassified to profit or loss: 
Exchange differences on retranslation of foreign continuing operations                     2,955             (3,580) 
Exchange differences on translation of discontinued operations                             (228)   (312) 
Items that will not be subsequently reclassified to profit or loss: 
Net loss on equity instruments at fair value through other comprehensive income            (12)    (1,996) 
 
Other comprehensive income/(loss) for the year (net of tax)                                2,715            (5,888) 
 
Total comprehensive income for the year attributable to owners of the Company              19,668            35,431 
 
Total comprehensive income for the year attributable to owners of the Company arises from: 
Continued operations                                                                       21,705  35,745 
Discontinued operations                                                                    (2,037) (314) 
                                                                                           19,668  35,431 

The above Consolidated Statement of Comprehensive Income should be read in conjunction with the accompanying notes.

consolidated statement of financial position 
as at 30 November 2020 
 
 
                                                                                  30 November       30 November 
                                                                                  2020              2019 
                                                                        Note       GBP'000             GBP'000 
ASSETS 
Non-current assets 
Property, plant and equipment                                                     40,818            6,804 
Intangible assets                                                                 4,409             8,031 
Investments                                                                       1                 13 
Deferred tax assets                                                               1,482                           4,167 
                                                                                  46,710                        19,015 
 
Current assets 
Trade and other receivables                                                       237,042                     270,350 
Current tax assets                                                                377               624 
Cash and cash equivalents                                               8         50,363                        15,093 
                                                                                  287,782                     286,067 
 
Total assets                                                                      334,492                     305,082 

(MORE TO FOLLOW) Dow Jones Newswires

January 25, 2021 02:02 ET (07:02 GMT)

© 2021 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.